Key result
Pulse pressure >60 mm Hg linked to ~32% higher cardio-cerebrovascular and mortality risk in stage 1 hypertensive men.
Why the study?
The study aimed to investigate the association of pulse pressure with cardio-cerebrovascular disease risk and all-cause mortality according to blood pressure level.
Does higher pulse pressure increase the risk of cardio-cerebrovascular disease and all-cause mortality in adults aged 40-69 years?
Cohort (n=211,333)
Yes
Does higher pulse pressure increase the risk of cardio-cerebrovascular disease and all-cause mortality in adults aged 40-69 years?
Effect estimate: HR 1.324 (95% CI 1.130-1.551)
Higher pulse pressure (>60 mm Hg) is significantly associated with an increased risk of cardio-cerebrovascular disease and all-cause mortality in hypertensive men, but not in women.
May aid risk stratification in stage 1 hypertensive men; hypothesis-generating and should not yet alter practice.
BACKGROUND: This study aimed to investigate the association of pulse pressure (PP) with the cardio-cerebrovascular disease (CCVD) risk and all-cause mortality according to blood pressure level using Korean national cohort data. METHODS: This study was retrospectively designed and based on the Korean National Health Insurance Service-National Health Screening Cohort. Participants aged 40-69 years at baseline were categorized into normal, elevated, stage 1, and stage 2 groups according to blood pressure. Each group was further classified into 5 groups separated by 10-mm Hg increments in PP. The primary composite outcome was defined as CCVDs and all-cause mortality. Cox proportional hazards regression models were adopted after stepwise adjustment for confounders to investigate the composite outcome. RESULTS: During the follow-up period (median follow-up period, 12.0 years), the primary composite outcome occurred in 18,444 (15.0%) of 122,783 men and 10,096 (11.4%) of 88,550 women. After complete adjustment for confounders, in the stage 1 hypertensive men, the hazard ratio (95% confidence intervals [CIs]) of the 31-40, 41-50, 51-60, and >60 mm Hg PP groups was 1.112 (1.013-1.221), 1.035 (0.942-1.137), 1.009 (0.907-1.123), and 1.324 (1.130-1.551) in comparison with the ≤30 mm Hg PP group. In the stage 2 hypertensive men, the HRs (95% CIs) were 1.069 (0.949-1.204), 1.059 (0.940-1.192), 1.123 (0.999-1.263), and 1.202 (1.061-1.358) compared to the ≤30 mm Hg PP group. However, these associations were not significant in women. CONCLUSIONS: Hypertensive men with an increased PP have an increased risk of CCVDs and all-cause mortality.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2022) conducted a cohort in Hypertension (n=211,333). Higher pulse pressure (>60 mm Hg) vs. Pulse pressure ≤30 mm Hg was evaluated on Cardio-cerebrovascular diseases and all-cause mortality (HR 1.324, 95% CI 1.130-1.551). In stage 1 hypertensive men, pulse pressure >60 mm Hg increased the risk of cardio-cerebrovascular disease and all-cause mortality compared to ≤30 mm Hg (HR 1.324; 95% CI 1.130-1.551).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: